Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

Por Hasenoehrl, Carina, Storr, Martin, Schicho, Rudolf
Publicado no Expert Rev Gastroenterol Hepatol (2017)

The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease

Por Hasenoehrl, Carina, Taschler, Ulrike, Storr, Martin, Schicho, Rudolf
Publicado no Neurogastroenterol Motil (2016)

Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn’s disease

Por Radnai, Balázs, Sturm, Eva M, Stančić, Angela, Jandl, Katharina, Labocha, Sandra, Ferreirós, Nerea, Grill, Magdalena, Hasenoehrl, Carina, Gorkiewicz, Gregor, Marsche, Gunther, Heinemann, Ákos, Högenauer, Christoph, Schicho, Rudolf
Publicado no J Crohns Colitis (2016)